Opendata, web and dolomites

PARADIGM SIGNED

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PARADIGM project word cloud

Explore the words cloud of the PARADIGM project. It provides you a very rough idea of what is the project "PARADIGM" about.

tools    strategy    consensus    innovative    engagement    patient    paradigm    pe    community    pharmaceutical   

Project "PARADIGM" data sheet

The following table provides information about the project.

Coordinator
FORUM EUROPEEN DES PATIENTS (FPE) 

Organization address
address: RUE DICKS 14
city: LUXEMBOURG
postcode: 1417
website: http://www.eu-patient.eu/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Luxembourg [LU]
 Total cost 9˙100˙277 €
 EC max contribution 4˙498˙931 € (49%)
 Programme 1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
 Code Call H2020-JTI-IMI2-2016-10-two-stage
 Funding Scheme /IMI2-RIA
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FORUM EUROPEEN DES PATIENTS (FPE) LU (LUXEMBOURG) coordinator 702˙516.00
2    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 621˙592.00
3    THE SYNERGIST BE (BRUXELLES) participant 543˙828.00
4    SYNAPSE RESEARCH MANAGEMENT PARTNERS SL ES (MADRID) participant 473˙500.00
5    EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION FR (Paris) participant 463˙597.00
6    STICHTING VU NL (AMSTERDAM) participant 458˙437.00
7    EUROPEAN AIDS TREATMENT GROUP EV DE (DUSSELDORF) participant 381˙750.00
8    ALZHEIMER EUROPE LU (LUXEMBOURG) participant 248˙500.00
9    EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE BE (BRUSSELS) participant 198˙000.00
10    INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD ES (ZARAGOZA) participant 181˙086.00
11    FUNDACIO SANT JOAN DE DEU ES (Esplugues de Llobregat) participant 176˙125.00
12    AGENZIA ITALIANA DEL FARMACO IT (ROMA) participant 50˙000.00
13    ALEXION SERVICES EUROPE SPRL BE (BRUSSELS) participant 0.00
14    AMGEN LIMITED UK (CAMBRIDGE) participant 0.00
15    BAYER AKTIENGESELLSCHAFT DE (Leverkusen) participant 0.00
16    COVANCE LABORATORIES LTD UK (HARROGATE) participant 0.00
17    Eli Lilly and Company Limited UK (Basingstoke) participant 0.00
18    F. HOFFMANN-LA ROCHE AG CH (BASEL) participant 0.00
19    FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES BE (BRUXELLES) participant 0.00
20    GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. UK (BRENTFORD) participant 0.00
21    GRUENENTHAL GMBH DE (AACHEN) participant 0.00
22    H. LUNDBECK AS DK (VALBY) participant 0.00
23    HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY CA (EDMONTON) participant 0.00
24    INSTITUT DE RECHERCHES INTERNATIONALES SERVIER FR (SURESNES) participant 0.00
25    JANSSEN PHARMACEUTICA NV BE (BEERSE) participant 0.00
26    MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN DE (DARMSTADT) participant 0.00
27    MERCK SHARP & DOHME CORP US (WHITEHOUSE STATION NJ) participant 0.00
28    NOVARTIS PHARMA AG CH (BASEL) participant 0.00
29    NOVO NORDISK A/S DK (BAGSVAERD) participant 0.00
30    PFIZER LIMITED UK (SANDWICH) participant 0.00
31    SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT FR (Chilly Mazarin) participant 0.00
32    THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY UK (LONDON) participant 0.00
33    UCB BIOPHARMA SPRL BE (BRUSSELS) participant 0.00
34    VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV DE (Berlin) participant 0.00

Mappa

 Project objective

PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engagement (PE) and demonstrates the ‘return on the engagement’ for all players. Much needed processes and tools for three key decision-making points (research priority setting, design of clinical trials and early dialogue) will be developed by consensus. Building on advances at international level, PARADIGM will integrate the needs, perspectives and expectations of all actors (including vulnerable populations) involved and will also produce a stakeholder-tailored set of metrics to measure the impact of PE. PARADIGM will deliver to the community, recommendations and tools to support the implementation of PE, leveraging pre-existing resources. These will address capacity and capability questions, managing potential conflict of interest, the compensation of individuals and organisations, and the ethics of engagement. A targeted communication, dissemination and engagement strategy will promote the endorsement of the outputs for their integration in existing structures. PARADIGM will develop a strategy for sustaining the long-term implementation of PE resources aimed at structuring and supporting the community. This will be a game-changer, addressing fundamental gaps and creating real assets to ensure the sustainability of the PE ecosystem in the years to come. PARADIGM has a common vision and values-base, and is a highly innovative, consensus-oriented, and experienced consortium, comprising pan-European leaders in patient engagement, academia, SMEs, health professionals, pharmaceutical and biotech companies, pharmaceutical corporate associations, and representatives of competent authorities, all bringing complementary know-how to partner with industry, and a strong commitment to transform patient engagement in Europe.

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PARADIGM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PARADIGM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

Hypo-RESOLVE (2018)

Hypoglycaemia - REdefining SOLutions for better liVEs

Read More  

IMI-PainCare (2018)

Improving the care of patients suffering from acute or chronic pain

Read More  

PIONEER (2018)

Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

Read More